Skip to Content
  • MyChart

    Log in to our secure, personalized website to manage your care (formerly myMDAnderson).

  • Request an Appointment

    If you are ready to make an appointment, select a button on the right. If you have questions about UT MD Anderson’s appointment process, our information page may be the best place to start.

    Appointment Information
    New Patients Current Patients Referring Physicians
  • Every Breakthrough
    Begins With You

    Gifts to UT MD Anderson’s historic philanthropic campaign help accelerate discovery, transform lives and bring hope to more patients than ever before.

    Learn more about Only Possible Here
    Donate Today only-possible-here-logo
The University of Texas MD Anderson Cancer Center
  • Clinical Trials
  • Locations
  • Careers
  • Contact Us
  • Our Doctors
    • Español
    • عربى
    • 中文
    • Türkçe
Clear
close
      MyChart
      Donate Today
      • Clinical Trials
      • Locations
      • Careers
      • Contact Us
        • Español
        • عربى
        • 中文
        • Türkçe
      • Request an Appointment
      • New Patients
      • Current Patients
      • Referring Physicians
      • Patients & Family
          • Becoming Our Patient Home
          • Why UT MD Anderson
          • Planning for Care
          • Getting to UT MD Anderson
          • While You're Here
          • International Center
          • Services and Amenities
          • Insurance & Billing
          • Second Opinion Appointments
          • Diagnosis & Treatment Home
          • Cancer Types
          • A New Diagnosis
          • Treatment Options
          • Care Centers & Clinics
          • Emotional & Physical Effects
          • Patient Support
          • Clinical Trials
          • Supporting a Loved One Home
          • Caregiver Roles & Challenges
          • Children and Teens
          • Taking Care of Yourself
          • Helping a UT MD Anderson Patient
          • Dealing with Loss
          • Life After Cancer Home
          • Follow-up Care After Cancer Treatment
          • Long-Term Effects of Cancer
          • Social & Emotional Impacts of Cancer
          • Legal & Financial Impacts of Cancer
          • Survivorship Week
        • Request an Appointment Current Patients

          Find information and resources for current and returning patients.

          Clinical Trials

          Learn about clinical trials at UT MD Anderson and search our database for open studies.

      • Prevention & Screening
          • Manage Your Risk Home
          • Tobacco Control
          • Diet
          • Body Weight
          • Physical Activity
          • Skin Safety
          • HPV
          • Hepatitis
          • Alcohol
          • Family History Home
          • Genetic Testing
          • Hereditary Cancer Syndromes
          • Genetic Counseling and Testing FAQs
          • Cancer Screenings Home
          • Mammograms & Breast Cancer Screening
          • Cervical Cancer Screening
          • Colorectal Cancer Screening
          • Endometrial Cancer Screening
          • Liver Cancer Screening
          • Lung Cancer Screening
          • Mobile Mammography
          • Ovarian Cancer Screening
          • Prostate Cancer Screening
          • Skin Cancer Screening
          • Women's Cancer Screening
          • Men's Cancer Screening
        • Cancer Prevention Center 

          The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.

      • Donors & Volunteers
          • Donate Home
          • Raise Money
          • Honor Loved Ones
          • Create Your Legacy
          • Endowments
          • Caring Fund
          • Matching Gifts
          • Foundation and Corporation Relations
          • Volunteer Home
          • Why Volunteer
          • On-Site Volunteers
          • Volunteer Endowment
          • Patient Experience
          • Teen Volunteer Leadership Program
          • Children's Cancer Hospital Councils
          • Other Ways to Help Home
          • Give Blood
          • Shop UT MD Anderson
          • Children's Art Project
          • Donate Goods or Services
          • Attend Events
          • Cord Blood Bank
          • Corporate Alliances Home
          • Current Alliances
        • Join the Campaign to End Cancer 

          Help us celebrate and fuel the groundbreaking innovations and transformative advancements that define UT MD Anderson.

      • For Physicians
          • Refer a Patient Home
          • Health Care Provider Resource Center
          • Referring Provider Team
          • Insurance Information
          • International Referrals
          • myMDAnderson for Physicians
          • Second Opinion Pathology
          • Clinical Trials Home
          • Clinical Tools & Resources Home
          • Clinical Calculators
          • Clinical Practice Algorithms
        • myMDAnderson for Physicians 

          Our personalized portal helps you refer your patients and communicate with their UT MD Anderson care team.

      • Research
          • Departments, Labs and Institutes Home
          • Departments and Divisions
          • Labs
          • Research Centers and Programs
          • Institutes
          • Specialized Programs of Research Excellence (SPORE) Grants
          • Research Areas Home
          • Basic Science
          • Translational Research
          • Clinical Research
          • Prevention & Personalized Risk Assessment
          • Research Resources Home
          • Excellence in Science
          • Core Facilities and Services
          • Conferences & Seminars
          • Why Research at UT MD Anderson
          • STRIDE
          • NCI-Designated Cancer Center
          • Data Resources
        • Clinical Trials 

          As part of our mission to eliminate cancer, UT MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.

      • Education & Training
          • Degree-Granting Schools Home
          • School of Health Professions
          • MD Anderson UTHealth Houston Graduate School
          • Research Training Home
          • Early Career Pathway Programs
          • Predoctoral Training
          • Postdoctoral Training
          • Mentored Faculty Programs
          • Career Development
          • Clinical Training Home
          • Graduate Medical Education
          • Clinical Education for Non-Physicians
          • Nursing Education & Training
          • Continuing Education & Review Courses
          • Simulation Center
          • Continuing Education & Professional Development Home
          • Continuing Professional Education/Conferences
          • Administrative Internships & Fellowships
          • Cancer Survivorship Professional Education
          • Leadership Institute
          • Patient Home Visits
          • Education Resources Home
          • Alumni Relations
          • Education Design Services
          • Awards & Recognitions
          • Academic Mentoring Council
          • Why UT MD Anderson & Houston
          • Outreach Programs Home
          • Project ECHO
          • Observer Programs
          • Comparative Effectiveness Training (CERTaIN)
          • Faculty Speakers Bureau
        • Apply to SHP

          Choose from 12 allied health programs at School of Health Professions.

          Research Trainees

          View open postdoctoral and other research trainee positions.

          GME Fellowships

          Learn about our graduate medical education residency and fellowship opportunities.

      Micah M Bhatti Image

      Micah M Bhatti, M.D., Ph.D

      Department of Laboratory Medicine, Division of Pathology-Lab Medicine Div

      Present Title & Affiliation

      Primary Appointment

      Associate Professor, Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

      Dual/Joint/Adjunct Appointment

      Associate Professor, Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas

      Education & Training

      Degree-Granting Education

      2007Indiana University School of Medicine, Indianapolis, Indiana, US, MD
      2005Indiana University, Indianapolis, Indiana, US, Ph.D. in Pharmacology & Toxicology
      2000Butler University, Indianapolis, Indiana, US, BS in Chemistry

      Postgraduate Training

      2014-2015Clinical Fellowship, Clinical Microbiology, Mayo Clinic, Rochester, Minnesota
      2010-2013Clinical Fellowship, Pediatric Infectious Disease, University of Chicago, Chicago, Illinois
      2007-2010Clinical Residency, Pediatrics, University of California - San Diego, San Diego, California

      Licenses & Certifications

      2015American Board of Pathology - Medical Microbiology
      2015Texas Medical License
      2013American Board of Pediatrics - Infectious Diseases
      2010American Board of Pediatrics - Pediatrics

      Experience & Service

      Faculty Academic Appointments

      Assistant Professor, Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2015 - 2022

      Administrative Appointments/Responsibilities

      Faculty Director, Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2019 - Present

      Electronic Medical Record and Laboratory Information Systems Officer, Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2017 - Present

      Faculty Director, Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2016 - Present

      Technical Director, Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2015 - Present

      Extramural Institutional Committee Activities

      Co-Chair, Beaker CP Steering Committee, The University of Texas MD Anderson Cancer Center, 2021 - Present

      Member, COVID-19 Core Leadership Team, The University of Texas MD Anderson Cancer Center, 2020 - 2024

      Member, Clinical Core Leadership Team, The University of Texas MD Anderson Cancer Center, 2020 - Present

      Member, Infection Control Committee, The University of Texas MD Anderson Cancer Center, 2016 - Present

      Member, Antimicrobial Stewardship Committee, The University of Texas MD Anderson Cancer Center, 2016 - Present

      Senator, Faculty Senate, The University of Texas MD Anderson Cancer Center, 2016 - 2021

      Organizer, World Rare Disease Day Committee, The University of Texas MD Anderson Cancer Center, 2013 - 2013

      Member, Resident Advocacy Grievance Council, The University of Texas MD Anderson Cancer Center, 2007 - 2010

      Member, Physician Scientist Development Program, The University of Texas MD Anderson Cancer Center, 2007 - 2010

      Member, Student Advisory Committee, The University of Texas MD Anderson Cancer Center, 2004 - 2005

      Co-Chair, Pharmacology & Toxicology Graduate Student Organization, The University of Texas MD Anderson Cancer Center, 2004 - 2005

      Co-Chair, Evening of the Arts, The University of Texas MD Anderson Cancer Center, 2003 - 2007

      Honors & Awards

      20212021 Quality Caring Award, MD Anderson Cancer Center
      2020LEADing Others Accelerate, MD Anderson Leadership Institute
      2015Mayo Clinic Quality Fellow - Bronze Level Certification, Mayo Clinic Quality Academy, Mayo Clinic, Rochester MN
      2007Certificate of Recognition for Leadership in Community Health, American Academy of Pediatrics
      2007K.K. Chen Award, Indiana University
      2007Lyman T. Meiks Research Award, Indiana University School of Medicine
      2005K.K. Chen Fellowship, Indiana University
      2004Judy Boyd-White Award, Indiana University
      2004First Place Poster Presentation, Northwestern University
      2001William H and Fern L. Groves Hardiman Research Scholarship, Indiana University

      Professional Memberships

      Southwestern Association for Clinical Microbiology

      2018 - Present

      College of American Pathology

      2016 - Present

      American Society of Microbiology

      2013 - Present

      Infectious Disease Society of America

      2010 - Present

      Selected Presentations & Talks

      Regional Presentations

      1. 2023. Strategies for Managing Taxonomic Changes in Microbiology. Invited. Monthly SWCAM Webinar. Houston, TX, US.
      2. 2022. Strategies for Managing Taxonomic Changes in Microbiology. Conference. Annual SWACM Conference. Kansas City, MO, US.
      3. 2014. Health Behaviors and Choices of Patient's at the Comer Family Flu Clinic. Conference. Chicago, IL, US.
      4. 2014. Comparing Rapid Identification of Pathogens in Positive Blood Cultures using FilmArray and Verigene Platforms. Conference. Pediatric Grand Rounds. Chicago, IL, US.
      5. 2004. Toxoplasma gondii histone acetyltransferases: different HATs for different occasions. Conference. Woods Hole, MA, US.
      6. 2004. Nuclear Trafficking of a Histone Acetylase in Toxoplasma gondii. Conference. Chicago, IL, US.
      7. 2004. Nuclear Trafficking of a Histone Acetylase in Toxoplasma gondii. Conference. Urbana, IL, US.
      8. 2003. A tale of two GCN5s: Deciphering the roles os a pair of novel histone acetyltransferases in Toxoplasma. Conference. Woods Hole, MA, US.
      9. 2003. Characterization of TgGCN5: A novel histone acetyltransferase in Toxoplasma gondii. Conference. Urbana, IL, US.

      International Presentations

      1. 2026. Diagnostic Stewardship in Immunocompromised Patients. Invited. 24th Symposium of the International Immunocompromised Host Society (ICHS). Houston, US.
      2. 2005. Nuclear Trafficking of a Histone Acetylase in Toxoplasma gondii. Conference. 8th International Congress on Toxoplasmosis. Corsica, FR.

      Formal Peers

      1. 2021. COVID-19 Vaccination: Questions & Answers. Invited. Houston, TX, US.
      Read More
      Less

      Selected Publications

      Peer-Reviewed Articles

      1. Yaghi, L, Chemaly, RF, Dib, RW, Shropshire, W, Cantu, S, Bhatti, MM, Chatterjee, P, Jinadatha, C, Spallone, A. The efficacy of a filtered handheld far-ultraviolet disinfection device for decontamination of high-touch surfaces in healthcare settings. Infection Control and Hospital Epidemiology 46(10):1027-1034, 2025. e-Pub 2025. PMID: 40910299.
      2. Shropshire, W, Song, X, Bremer, J, Seo, S, Rodriguez, S, Selvaraj-Anand, S, Dinh, AQ, Bhatti, MM, Konovalova, A, Arias, CA, Kalia, A, Shamoo, Y, Shelburne, S. Comprehensive Assessment of Initial Adaptation of Extended-Spectrum β-Lactamase–Positive ST131 Escherichia coli to Carbapenem Exposure. Journal of Infectious Diseases 231(4):e685-e696, 2025. e-Pub 2025. PMID: 39602497.
      3. Daher, M, Khawaja, F, Spallone, A, Shigle, TL, Bhatti, MM, Vuong, NN, Ariza Heredia, E, Mulanovich, VE, Champlin, RE, Chemaly, RF. Real-World Experience With Maribavir for Treatment of Refractory or Resistant Cytomegalovirus Infection in Hematopoietic Cell Transplant Recipients and Hematologic Malignancy Patients. Transplant Infectious Disease 27(2), 2025. e-Pub 2025. PMID: 39826146.
      4. Wu, CT, Shropshire, W, Bhatti, MM, Cantu, S, Glover, I, Anand, SS, Liu, X, Kalia, A, Treangen, TJ, Chemaly, RF, Spallone, A, Shelburne, S. Rapid whole genome characterization of antimicrobial-resistant pathogens using long-read sequencing to identify potential healthcare transmission. Infection Control and Hospital Epidemiology 46(2):129-135, 2025. e-Pub 2025. PMID: 39727230.
      5. Angelidakis, G, Chemaly, RF, Sahasrabhojane, P, Morado-Aramburo, O, Jiang, Y, Bhatti, MM, Shpall, EJ, Hosing, C, Jain, P, Mahadeo, KM, Khawaja, F, Elhajj, P, Wargo, J, Jenq, RR, Ajami, NJ, Kebriaei, P, Ariza Heredia, E. Humoral Immunity and Antibody Responses against Diphtheria, Tetanus, and Pneumococcus after Immune Effector Cell Therapies. Vaccines 12(9), 2024. e-Pub 2024. PMID: 39340100.
      6. Shropshire WC, Song X, Bremer J, Seo S, Rodriguez S, Anand SS, Dinh AQ, Bhatti MM, Konovalova A, Arias CA, Kalia A, Shamoo Y, Shelburne SA. Comprehensive Assessment of Initial Adaptation of ESBL Positive ST131 Escherichia coli to Carbapenem Exposure. bioRxiv, 2024. e-Pub 2024. PMID: 39211100.
      7. Chiu, CY, Mustafayev, K, Bhatti, MM, Jiang, Y, Granwehr, BP, Torres, HA. False-Reactive Fourth-Generation Human Immunodeficiency Virus Testing in Cancer Patients. Clinical Infectious Diseases 78(3):674-680, 2024. e-Pub 2024. PMID: 37930789.
      8. Kawai, A, Shropshire, WC, Suzuki, M, Borjan, J, Aitken, SL, Bachman, WC, Mcelheny, CL, Bhatti, MM, Shields, RK, Shelburne, S, Doi, Y. Structural insights into the molecular mechanism of high-level ceftazidime–avibactam resistance conferred by CMY-185. mBio 15(2), 2024. e-Pub 2024. PMID: 38179965.
      9. Anand, SS, Wu, CT, Bremer, J, Bhatti, MM, Treangen, TJ, Kalia, A, Shelburne, S, Shropshire, WC. Identification of a novel CG307 sub-clade in third-generation-cephalosporin-resistant Klebsiella pneumoniae causing invasive infections in the USA. Microbial genomics 10(2), 2024. e-Pub 2024. PMID: 38407244.
      10. Khawaja, F, Angelidakis, G, Feldman, A, Ravi, V, Woodman, E, Bhatti, MM, Ariza Heredia, E, Elhajj, P, Spallone, A, Jiang, Y, Chemaly, RF. COVID-19 in cancer patients. Cancer medicine 12(24):22006-22022, 2023. e-Pub 2023. PMID: 38063366.
      11. Franklin, A, John, TM, Khawaja, F, Jiang, Y, Yepez, E, Ahuja, J, Faiz, S, Bashoura, L, Sheshadri, A, Shannon, VR, Balachandran, D, Mcconn, KK, Mulanovich, VE, Bhatti, MM, Chemaly, RF. Utility of Bronchoalveolar Lavage for the Diagnosis and Management of COVID-19 in Patients with Cancer. Journal of Infectious Diseases 228(11):1549-1558, 2023. e-Pub 2023. PMID: 37983000.
      12. Axell-House, DB, Nagarajan, P, Bhatti, MM, Mehta, RS, Roy, S, Ali, IM, John, TM. Endophthalmitis, Cutaneous Nodules, and Brain Lesions in Stem Cell Transplant Recipient. Clinical Infectious Diseases 77(8):1212-1215, 2023. e-Pub 2023. PMID: 37831593.
      13. Shropshire, WC, Endres, BT, Borjan, J, Aitken, SL, Bachman, WC, Mcelheny, CL, Wu, CT, Egge, SL, Khan, A, Miller, WR, Bhatti, MM, Saharasbhojane, P, Kawai, A, Shields, RK, Shelburne, S, Doi, Y. High-level ceftazidime/avibactam resistance in Escherichia coli conferred by the novel plasmid-mediated β-lactamase CMY-185 variant. Journal of Antimicrobial Chemotherapy 78(10):2442-2450, 2023. e-Pub 2023. PMID: 37574665.
      14. Shropshire, WC, Strope, B, Anand, SS, Bremer, J, McDaneld, PM, Bhatti, MM, Flores, AR, Kalia, A, Shelburne, S. Temporal dynamics of genetically heterogeneous extended-spectrum cephalosporin-resistant Escherichia coli bloodstream infections. mSphere 8(4), 2023. e-Pub 2023. PMID: 37427953.
      15. Khawaja, F, Srinivasan, K, Spallone, A, Feldman, A, Cantu, S, Ariza Heredia, E, Dvordak, T, Alousi, AM, Ahmed, S, George, MC, Frenzel, E, Bhatti, MM, Chemaly, RF. Nosocomial COVID-19 at a comprehensive cancer center during the first year of the pandemic. American Journal of Infection Control 51(5):506-513, 2023. e-Pub 2023. PMID: 35901993.
      16. Shropshire WC, Konovalova A, McDaneld P, Gohel M, Strope B, Sahasrabhojane P, Tran CN, Greenberg D, Kim J, Zhan X, Aitken S, Bhatti M, Savidge TC, Treangen TJ, Hanson BM, Arias CA, Shelburne SA. Systematic Analysis of Mobile Genetic Elements Mediating β-Lactamase Gene Amplification in Noncarbapenemase-Producing Carbapenem-Resistant Enterobacterales Bloodstream Infections. mSystems 7(5):e0047622, 2022. e-Pub 2022. PMID: 36036505.
      17. Bhalodi AA, MacVane SH, Ford B, Ince D, Kinn PM, Percival KM, Bremmer DN, Carr DR, Walsh TL, Bhatti MM, Shelburne SA, Humphries RM, Wolfe K, Rosenbaum ER, Dare RK, Kolev J, Madhusudhan M, Ben-Aderet MA, Morgan MA. Real-World Impact of the Accelerate PhenoTest ® BC Kit on patients with bloodstream infections in IOAS (Improving Outcomes and Antimicrobial Stewardship): A Quasi-Experimental Multicenter Study. Clin Infect Dis 75(2):269-277, 2022. e-Pub 2021. PMID: 34718456.
      18. Khan A, Erickson SG, Pettaway C, Arias CA, Miller WR, Bhatti MM. Evaluation of susceptibility testing methods for aztreonam (ATM) and ceftazidime/avibactam (CZA) combination therapy on extensively drug-resistant Gram-negative organisms. Antimicrob Agents Chemother 65(11):AAC0084621, 2021. e-Pub 2021. PMID: 34424044.
      19. Khan A, Arias CA, Abbott A, Dien Bard J, Bhatti MM, Humphries RM. Evaluation of the Vitek 2, Phoenix, and MicroScan for Antimicrobial Susceptibility Testing of Stenotrophomonas maltophilia. J Clin Microbiol 59(9):e0065421, 2021. e-Pub 2021. PMID: 34011524.
      20. Karri PV, Torres CA, Dailey Garnes NJ, Ronen S, Khawaja F, Bhatti MM, Hosing C, Patel AB. Disseminated atypical mycobacterial infection in an allogeneic stem cell transplant recipient. Dermatol Online J 27(6), 2021. e-Pub 2021. PMID: 34387060.
      21. Khan A, Pettaway CH, Dien Bard J, Arias CA, Bhatti MM, Humphries RM. Erratum for Khan et al., "Evaluation of the Performance of Manual Antimicrobial Susceptibility Testing Methods and Disk Breakpoints for Stenotrophomonas maltophilia". Antimicrob Agents Chemother 65(6), 2021. e-Pub 2021. PMID: 34006614.
      22. Yepez Guevara EA, Aitken SL, Olvera AV, Carlin L, Fernandes KE, Bhatti MM, Garey KW, Adachi J, Okhuysen PC. Clostridioides difficile Infection in Cancer and Immunocompromised Patients: Relevance of a Two-step Diagnostic Algorithm and Infecting Ribotypes on Clinical Outcomes. Clin Infect Dis 72(10):e460-e465, 2021. e-Pub 2021. PMID: 32803229.
      23. Olvera A, Carter H, Rajan A, Carlin LG, Yu X, Zeng XL, Shelburne S, Bhatti M, Blutt SE, Shroyer NF, Jenq R, Estes MK, Maresso A, Okhuysen PC. Enteropathogenic Escherichia coli Infection in Cancer and Immunosuppressed Patients. Clin Infect Dis 72(10):e620-e629, 2021. e-Pub 2021. PMID: 32930708.
      24. Khan A, Pettaway C, Dien Bard J, Arias CA, Bhatti MM, Humphries RM. Evaluation of the Performance of Manual Antimicrobial Susceptibility Testing Methods and Disk Breakpoints for Stenotrophomonas maltophilia. Antimicrob Agents Chemother 65(5), 2021. e-Pub 2021. PMID: 33558287.
      25. Shropshire WC, Aitken SL, Pifer R, Kim J, Bhatti MM, Li X, Kalia A, Galloway-Peña J, Sahasrabhojane P, Arias CA, Greenberg DE, Hanson BM, Shelburne SA. IS26-mediated amplification of blaOXA-1 and blaCTX-M-15 with concurrent outer membrane porin disruption associated with de novo carbapenem resistance in a recurrent bacteraemia cohort. J Antimicrob Chemother 76(2):385-395, 2021. e-Pub 2021. PMID: 33164081.
      26. Szvalb AD, Malek AE, Jiang Y, Bhatti MM, Wurster S, Kontoyiannis DP. Serum (1,3)-Beta-d-Glucan has suboptimal performance for the diagnosis of Pneumocystis jirovecii pneumonia in cancer patients and correlates poorly with respiratory burden as measured by quantitative PCR. J Infect 81(3):443-451, 2020. e-Pub 2020. PMID: 32650108.
      27. Wang EW, Bhatti M, Cantu S, Okhuysen PC. Diagnosis of Yersinia enterocolitica Infection in Cancer Patients With Diarrhea in the Era of Molecular Diagnostics for Gastrointestinal Infections. Open Forum Infect Dis 6(4):ofz116, 2019. e-Pub 2019. PMID: 31049362.
      28. Benanti GE, Brown ART, Shigle TL, Tarrand JJ, Bhatti MM, McDaneld PM, Shelburne SA, Aitken SL. Carbapenem versus Cefepime or Piperacillin-Tazobactam for Empiric Treatment of Bacteremia Due to Extended-Spectrum-β-Lactamase-Producing Escherichia coli in Patients with Hematologic Malignancy. Antimicrob Agents Chemother 63(2), 2019. e-Pub 2019. PMID: 30509935.
      29. Mah A, Viola GM, Ariza Heredia E, Rezvani K, Kebriaei P, Bhatti MM, Han X, Shpall EJ, Mulanovich VE. Graft loss attributed to possible transfusion-transmitted ehrlichiosis following cord blood stem cell transplant. Transpl Infect Dis 20(4):e12899, 2018. e-Pub 2018. PMID: 29668040.
      30. Li X, Arias CA, Aitken SL, Galloway Peña J, Panesso D, Chang M, Diaz L, Rios R, Numan Y, Ghaoui S, DebRoy S, Bhatti MM, Simmons DE, Raad I, Hachem R, Folan SA, Sahasarabhojane P, Kalia A, Shelburne SA. Clonal Emergence of Invasive Multidrug-Resistant Staphylococcus epidermidis Deconvoluted via a Combination of Whole-Genome Sequencing and Microbiome Analyses. Clin Infect Dis 67(3):398-406, 2018. e-Pub 2018. PMID: 29546356.
      31. Madigan, T, Cunningham, SA, Ramanan, P, Bhatti, MM, Patel, R. Real-Time PCR Assay for Detection of Kingella kingae in Children. Journal of Pediatric Infectious Diseases 13(3):216-223, 2018. e-Pub 2018.
      32. Galloway-Peña J, DebRoy S, Brumlow C, Li X, Tran TT, Horstmann N, Yao H, Chen K, Wang F, Pan BF, Hawke DH, Thompson EJ, Arias CA, Fowler VG, Bhatti MM, Kalia A, Flores AR, Shelburne SA. Hypervirulent group A Streptococcus emergence in an acaspular background is associated with marked remodeling of the bacterial cell surface. PLoS One 13(12):e0207897, 2018. e-Pub 2018. PMID: 30517150.
      33. Chao AW, Bhatti MM, DuPont HL, Nataro JP, Carlin LG, Okhuysen PC. Clinical features and molecular epidemiology of diarrheagenic Escherichia coli pathotypes identified by fecal gastrointestinal multiplex nucleic acid amplification in patients with cancer and diarrhea. Diagn Microbiol Infect Dis 89(3):235-240, 2017. e-Pub 2017. PMID: 28931467.
      34. Ariza-Heredia EJ, Granwehr BP, Viola GM, Bhatti M, Kelley JM, Kochenderfer J, Hosing C. False-positive HIV nucleic acid amplification testing during CAR T-cell therapy. Diagn Microbiol Infect Dis 88(4):305-307, 2017. e-Pub 2017. PMID: 28610774.
      35. Khan M, Siddiqi R, Konopleva M, Bhatti MM, Benton CB. Increased peripheral leukemia blasts leading to false-positive blood culture. Blood Cells Mol Dis 64:8-9, 2017. e-Pub 2017. PMID: 28285097.
      36. Ghosh T, Jandhyala D, Bhatti MM, Pritt BS. Closing the Brief Case: Crusted Scabies in a Leukemic Patient following a Stay in a Long-Term Acute Care Facility. J Clin Microbiol 55(5):1599-1600, 2017. e-Pub 2017. PMID: 28442617.
      37. Ghosh T, Jandhyala D, Bhatti MM, Pritt BS. The Brief Case: Crusted Scabies in a Leukemic Patient following a Stay in a Long-Term Acute Care Facility. J Clin Microbiol 55(5):1233-1236, 2017. e-Pub 2017. PMID: 28442611.
      38. Bhatti MM, Rucinski SL, Schwab JJ, Cole NC, Gebrehiwot SA, Patel R. Eight-Year Review of Bordetella pertussis Testing Reveals Seasonal Pattern in the United States. J Pediatric Infect Dis Soc 6(1):91-93, 2017. e-Pub 2017. PMID: 26621328.
      39. Bhatti MM, Kalia A, Sahasrabhojane P, Kim J, Greenberg DE, Shelburne SA. Identification and Whole Genome Sequencing of the First Case of Kosakonia radicincitans Causing a Human Bloodstream Infection. Front Microbiol 8(JAN):62, 2017. e-Pub 2017. PMID: 28174569.
      40. Aitken SL, Tarrand JJ, Deshpande LM, Tverdek FP, Jones AL, Shelburne SA, Prince RA, Bhatti MM, Rolston KVI, Jones RN, Castanheira M, Chemaly RF. High Rates of Nonsusceptibility to Ceftazidime-avibactam and Identification of New Delhi Metallo-β-lactamase Production in Enterobacteriaceae Bloodstream Infections at a Major Cancer Center. Clin Infect Dis 63(7):954-8, 2016. e-Pub 2016. PMID: 27313265.
      41. Aitken SL, Kontoyiannis DP, DePombo AM, Bhatti MM, Tverdek FP, Gettys SC, Nicolau DP, Nunez CA. Use of Ceftolozane/Tazobactam in the Treatment of Multidrug-resistant Pseudomonas aeruginosa Bloodstream Infection in a Pediatric Leukemia Patient. Pediatr Infect Dis J 35(9):1040-2, 2016. e-Pub 2016. PMID: 27254038.
      42. Cawcutt KA, Bhatti MM, Nelson DR. Pleural fluid infection caused by Dietzia cinnamea. Diagn Microbiol Infect Dis 85(4):496-7, 2016. e-Pub 2016. PMID: 27312689.
      43. Shah NS, Greenberg JA, McNulty MC, Gregg KS, Riddell J, Mangino JE, Weber DM, Hebert CL, Marzec NS, Barron MA, Chaparro-Rojas F, Restrepo A, Hemmige V, Prasidthrathsint K, Cobb S, Herwaldt L, Raabe V, Cannavino CR, Hines AG, Bares SH, Antiporta PB, Scardina T, Patel U, Reid G, Mohazabnia P, Kachhdiya S, Le BM, Park CJ, Ostrowsky B, Robicsek A, Smith BA, Schied J, Bhatti MM, Mayer S, Sikka M, Murphy-Aguilu I, Patwari P, Abeles SR, Torriani FJ, Abbas Z, Toya S, Doktor K, Chakrabarti A, Doblecki-Lewis S, Looney DJ, David MZ. Bacterial and viral co-infections complicating severe influenza: Incidence and impact among 507 U.S. patients, 2013-14. J Clin Virol 80:12-9, 2016. e-Pub 2016. PMID: 27130980.
      44. Shah NS, Greenberg JA, McNulty MC, Gregg KS, Riddell J, Mangino JE, Weber DM, Hebert CL, Marzec NS, Barron MA, Chaparro-Rojas F, Restrepo A, Hemmige V, Prasidthrathsint K, Cobb S, Herwaldt L, Raabe V, Cannavino CR, Hines AG, Bares SH, Antiporta PB, Scardina T, Patel U, Reid G, Mohazabnia P, Kachhdiya S, Le BM, Park CJ, Ostrowsky B, Robicsek A, Smith BA, Schied J, Bhatti MM, Mayer S, Sikka M, Murphy-Aguilu I, Patwari P, Abeles SR, Torriani FJ, Abbas Z, Toya S, Doktor K, Chakrabarti A, Doblecki-Lewis S, Looney DJ, David MZ. Severe Influenza in 33 US Hospitals, 2013-2014: Complications and Risk Factors for Death in 507 Patients. Infect Control Hosp Epidemiol 36(11):1-10, 2015. e-Pub 2015. PMID: 26224364.
      45. Bhatti MM, Boonlayangoor S, Beavis KG, Tesic V. Rapid identification of positive blood cultures by matrix-assisted laser desorption ionization-time of flight mass spectrometry using prewarmed agar plates. J Clin Microbiol 52(12):4334-8, 2014. e-Pub 2014. PMID: 25232166.
      46. Bhatti MM, Boonlayangoor S, Beavis KG, Tesic V. Evaluation of FilmArray and Verigene systems for rapid identification of positive blood cultures. J Clin Microbiol 52(9):3433-6, 2014. e-Pub 2014. PMID: 25031445.
      47. Ouederni M, Sanal O, Ikinciogullari A, Tezcan I, Dogu F, Sologuren I, Pedraza-Sánchez S, Keser M, Tanir G, Nieuwhof C, Colino E, Kumararatne D, Levy J, Kutukculer N, Aytekin C, Herrera-Ramos E, Bhatti MM, Karaca N, Barbouche R, Broides A, Goudouris E, Franco JL, Parvaneh N, Reisli I, Strickler A, Shcherbina A, Somer A, Segal A, Angel-Moreno A, Lezana-Fernandez JL, Bejaoui M, Bobadilla-Del Valle M, Kachboura S, Sentongo T, Ben-Mustapha I, Bustamante J, Picard C, Puel A, Boisson-Dupuis S, Abel L, Casanova JL, Rodríguez-Gallego C. Clinical features of Candidiasis in patients with inherited interleukin 12 receptor β1 deficiency. Clin Infect Dis 58(2):204-13, 2014. e-Pub 2014. PMID: 24186907.
      48. Nash, C, Chu, A, Bhatti, MM, Alexander, K, Schreiber, M, Hageman, JR. Coagulase negative staphylococci in the neonatal intensive care unit. NeoReviews 14(6):e284-e293, 2013. e-Pub 2013.
      49. Bhatti, MM, Chu, A, Hageman, JR, Schreiber, M, Alexander, K. Future directions in the evaluation and management of neonatal sepsis. Pediatrics in Review 13(2):e103-e110, 2012. e-Pub 2012.
      50. Dixon SE, Bhatti MM, Uversky VN, Dunker AK, Sullivan WJ. Regions of intrinsic disorder help identify a novel nuclear localization signal in Toxoplasma gondii histone acetyltransferase TgGCN5-B. Mol Biochem Parasitol 175(2):192-5, 2011. e-Pub 2011. PMID: 21055425.
      51. Bhatti MM, Livingston M, Mullapudi N, Sullivan WJ. Pair of unusual GCN5 histone acetyltransferases and ADA2 homologues in the protozoan parasite Toxoplasma gondii. Eukaryot Cell 5(1):62-76, 2006. e-Pub 2006. PMID: 16400169.
      52. Saksouk N, Bhatti MM, Kieffer S, Smith AT, Musset K, Garin J, Sullivan WJ, Cesbron-Delauw MF, Hakimi MA. Histone-modifying complexes regulate gene expression pertinent to the differentiation of the protozoan parasite Toxoplasma gondii. Mol Cell Biol 25(23):10301-14, 2005. e-Pub 2005. PMID: 16287846.
      53. Bhatti MM, Sullivan WJ. Histone acetylase GCN5 enters the nucleus via importin-alpha in protozoan parasite Toxoplasma gondii. J Biol Chem 280(7):5902-8, 2005. e-Pub 2005. PMID: 15591057.
      54. Sullivan WJ, Narasimhan J, Bhatti MM, Wek RC. Parasite-specific eIF2 (eukaryotic initiation factor-2) kinase required for stress-induced translation control. Biochem J 380(Pt 2):523-31, 2004. e-Pub 2004. PMID: 14989696.
      55. Carlson, MW, Ciszewski, JT, Bhatti, MM, Swanson, WF, Wilson, AM. A Simple Secondary Amine Synthesis. Journal of Chemical Education 77(2):270-271, 2000. e-Pub 2000.

      Review Articles

      1. Ragoonanan D, Khazal SJ, Mejia R, Ewing L, Durand JB, Bashoura L, Tayar J, Dailey Garnes N, Petropoulos D, Tewari P, Bhatti M, Ahmad AH, Cortes J, Razvi S, McBeth K, Swinford R, Shoberu B, Waseemuddin W, Chi L, Gill JB, Zaky W, Daw N, Gutierrez C, Tereffe W, Kebriaei P, Rezvani K, Shpall EJ, Champlin RE, Mahadeo KM. Case Discussion and Literature Review: Cancer Immunotherapy, Severe Immune-Related Adverse Events, Multi-Inflammatory Syndrome, and Severe Acute Respiratory Syndrome Coronavirus 2. Front Oncol 11:625707, 2021. e-Pub 2021. PMID: 33614514.

      Book Chapters

      1. Heaton PR, Bhatti MM. Systems for Identification of Bacteria and Fungi. In: Manual of Clinical Microbiology. 13th. ASM Press, 2023.
      2. Bhatti, MM, Enzler, M. Approach to Diarrhea in Returned Travelers. In: The Travel and Tropical Medicine Manual. Fifth. Elsevier, 415-428, 2016.
      Read More
      Less

      Patient Reviews


      CV information above last modified July 22, 2026

      Request an Appointment

      Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.
      Learn more

      Related Links

      • Care Centers and Clinics

      • Departments and Divisions

      • Labs

      Clinical Trials

      Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.
      Learn more

      Help #EndCancer

      Give Now

      Your gift will help make a tremendous difference.
      Donate

      Donate Blood

      Our patients depend on blood and platelet donations.

      Make an appointment

      Shop UT MD Anderson

      Show your support for our mission through branded merchandise.

      View products
      Subscribe to our Cancerwise newsletter
      UT MD Anderson logoUT MD Anderson logo
      • Explore
      • Patients & Family
      • Prevention & Screening
      • Donors & Volunteers
      • For Physicians
      • Research
      • Education & Training
      • Clinical Trials
      • Languages
      • About
      • About UT MD Anderson
      • Careers
      • Blog
      • Newsroom
      • Editorial Standards
      • For Employees
      • Merchandise
      • Title IX Reporting (Sexual Misconduct)
      • Price Transparency
      • Finding Your Way
      • Our Doctors
      • Locations
      • Directions
      • Sitemap
      • DIGITAL ACCESSIBILITY
      • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
      • GET IN TOUCH
      • Call
        1-877-632-6789
      • Ask a question
      • Stay Connected
      • Cancerwise Podcast
      • More
      • Website Privacy Policy
      • Legal Statement & Policies
      • Reports to the State
      • Emergency Alert Information
      • State of Texas Links
      • Our Cancer Network
      • Vendors & Suppliers
      UT MD Anderson logo
      The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

      © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

      Top